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In 1996 and 1997, Glaxo Wellcome’s US Research division
planned and established their second generation research strategy.
An important aspect of the strategy entailed development of two
automated screening sites in Biochemistry in Research Triangle
Park, VC. Development of the new operations required many
decisions to be made very quickly, including automated process
design, system selection and site preparation. Descriptions of the
decision made in the development of one of the screening sites are
presented in this paper.
Introduction
(for example data handling, hit identification), and the
automation of many of those processes.
Many of the final workgroup reports recommended that
two centralized automated screening sites be developed
in RTP. This recommendation became an integral part
of the ensuing implementation effort. Both screening sites
are in departments in US Biochemistry and reside in
separate buildings: one site is in a main R&D complex
and the other is in a satellite building several miles away
from the main site. The development of the site in the
satellite building is described herein.
Many decisions were made during site development,
including workflow (processes and organization) and
resources (space, people and instruments). All decisions
were made and implemented in less than a year. Some dec-
isions were easy to make; others were difficult. The more
difficult or complicated decisions are the focus below.
During 1996 and 1997, scientists at Glaxo Wellcome’s
(GW) Research Triangle Park, North Carolina (RTP)
site planned and implemented their second generation
US Research Strategy. This strategy called for the
development of more efficient processes to help ensure
that the world-wide corporation achieves its overall goals
for the coming years. Thirteen workgroups of scientists
were formed in early 1996 to plan the new processes.
Each workgroup focused on a specific area, such as
automation, data handling, lead optimization or com-
pound distribution. The workgroups were small, usually
six to 10 scientists selected from across research, develop-
ment and information technology. In all, over 100
scientists participated in formulating the plans.
The workgroups were given three months to compile
recommendations and submit reports to senior manage-
ment. They formulated recommendations through col-
lection and analysis of existing data, intra- and inter-
group discussions, project meetings, and interviews with
and feedback questionnaires from scientists through the
organization.
When they received the 13 reports, senior management
studied them and devised one overall strategy. Within
one month the managers and scientists started the im-
plementation of the second generation strategy. Within
another month, implementation of the strategy was
moving at full speed. Since then the original recommen-
dations from the 13 workgroups have provided the back-
bone for on-going implementation.
A very large part of the strategy focuses on the processes
surrounding high throughput primary screening (HTS)
and secondary screening, including the processes that
feed into them (for example compound distribution,
assay development), the processes that they feed into
Site functions
Most of the functions of automated screening site were
predetermined by, and fall within, the scope of the
department: primary target screening to identify hits
and secondary screening to confirm and evaluate hits.
The decision to add compound handling functions was
made three months into the planning process. Com-
pounds received from a central inventory and distribu-
tion unit are prepared for the assays at the screening site.
To decide how we would
required decisions on:
automate these processes
site processes and organization;
selection and purchase of instruments;
construction of space for automated systems.
Site processes and organization
Processes and organization--options
Automated screening processes are performed and groups
are organized in many different ways across Glaxo Well-
come and the pharmaceutical industry. Process flow is
largely determined by the way that people are organized,
even though the reverse scenario is usually the preferred
one. While screening processes were being developed at
this site, the following options for organization were
available: organization of automation expertise could
be centralized or non-centralized and organization of
assay operations could be centralized or non-centralized.
Centralized automation expertise: centralized groups of scien-
tists that are dedicated to setting up automated systems are
very common in laboratory automation. The greatest benefit
to this arrangement is that it recognizes the significant level
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of focused effort required to set up and maintain most
automated systems. Its largest pitfall is the workflow: full
centralization places boundaries in workflow, particularly
between the system developers and the assay developers.
Centralized screen operation: centralized groups that are
dedicated to running screens are also common; often it is
the same group that has centralized automation expertise.
The benefit of this arrangement is speed and efficiency:
the screens operate as assembly-line processes. The down-
side to this arrangement is that, while it eliminates bound-
aries within screen conduct, it places stricter peripheral
boundaries. For instance, the original assay developers,
the primary screeners and the secondary screeners are
often in different departments or divisions, and assays are
developed as each of those boundaries is crossed. The ease
by which those boundaries are crossed depends on the
quality of communication and commonality of goals,
which often depend on political organization. The closer
these groups are situated politically in the organization,
the easier it is to work across the boundaries.
Von-centralized automation expertise: non-centralized auto-
mation expertise often develops where a decision to auto-
mate is made locally and is not part of a strategic initiative
in which resources are made available for personnel, space,
etc. The benefits of this arrangement are that it is less ex-
pensive (in the short term), and it can be a very good way
for an organization to get started with and learn about
automation. The pitfall is that successful implementation
often takes too long to achieve and confidence in benefits
of automation is eroded. If it is successful, expansion is
more difficult, because space, personnel and workflow to
support expansion are not adequately pre-planned.
/Von-centralized screen operation: non-centralized system op-
eration is also sometimes referred to as walk-up opera-
tion. People use the system when they have an assay to
run, rather than handing the assay off to a central
screening group. A great benefit to this scheme is that
the assay hand-off is eliminated. The major risk in this
scheme is that the operators often know little about the
systems and rely on others to set up and trouble-shoot
them. It works best with readily available, local expertise.
Process and organization--decisions
It was decided that a core group of laboratory automa-
tion experts should be formed in the screening depart-
ment to be physically and politically teamed with the
scientists who develop the target screens. To avoid
hierarchical segregation and to foster buy-in to the new
strategy quickly, it was next decided that all scientists in
the department who have targets to screen would be
involved in screening them. Thus a centralized automa-
tion group was formed to develop, set up, and maintain
automation in the department and that would work with
scientists (known as target co-ordinators) to automate the
target assays. The target co-ordinators would be respon-
sible for developing the assays, supplying reagents, load-
ing and running the systems and handling data.
Selection and purchase of instruments
Automated instruments--options
Amongst the scientists and laboratories of Glaxo Well-
come is extensive experience with most types of labora-
tory automation software and hardware. Information on
the performance of the many different systems and ven-
dors is available from GW colleagues all over the world.
From this information it may be concluded that a skilled,
focused automation group would be able to maintain and
operate virtually any type of system available, or could
learn to do so. The deadline for site setup was challen-
ging, therefore the realistic options available included
systems that could be set up, operated and maintained
quickly. This limited the systems to those that the people
in the automation group and/or department and/or
adjunct departments already knew how to set up, pro-
gram and maintain. These systems are listed in table 1.
All instrument purchasing decisions were made from the
options listed above.
Automated instruments--decisions
Execution of very high throughput screens was immedi-
ately assigned to full robotic systems. This decision was
made to allow full automation of the assays and free
scientists to work on other responsibilities, such as data
handling, while the assays are running. Additional semi-
automated workstations were installed in most labora-
tories to help scientists develop assays that are most easily
and successfully scaled up to full robot systems. Second-
ary screening is also automated and the semi-automated
workstations are also used to do this work. Scientists in
the department underwent (and continue to undergo)
training to operate the standalone instruments.
A typical assay automation scheme:
Tecan Genesis (R) =:> Full track robot => Tecan Genesis (R)
Assay development-Primary screening-Secondary screening
Decisions on the specific vendors to purchase the instru-
ments from were based on existing expertise, instrument
flexibility and vendor flexibility. Additionally, we
decided not to use third-party integrators.
Table 1.
Hardware Software
Beckman/Sagian: ORCA(R), Biomek
)’
Packard: Multiprobe
(R)
Tecan: Genesis ORCA
Zymark: Zymateq series
Beckman/Sagian: MSD (R), SAMI (R), Bioworks (R)
Packard: EasyPrep
(R)
Scitech: WinClara(R), Clara (R)
Tecan: Logic Integrator, Toolbox
(R) (R) Zymark: EasyLab PCS
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The semi-automated workstation decision was made
based on flexibility and local expertise. A unit that
could handle very low volumes of liquids in 96 and 384
format, provide cold storage for reagents, be easily
customized for new racks and had the flexibility to be
integrated with any new full robot system, was needed.
At the time the decision was made, only one vendor could
fulfil all of those requirements and be supported using
internal expertise. Units that were purchased and in-
stalled before these decisions were made also are routinely
used and maintained.
While deciding on which type of full robot system to
purchase, the selection was narrowed to two vendors
based on existing systems, existing expertise and the
elimination of third-party integrators. The final deter-
mining factors were vendor responsiveness and flexibility
to meet our needs for on-going service, support, training
and technology development. One vendor offered these
benefits immediately. Systems purchased and installed
before these decisions were made also are routinely
operated and maintained.
Space for automated systems
Space--options
Like the groups and the workflow, space may be central
or distributed. Centralized labs are commonly used for
full robot systems, mainly because they require so much
space. The space allocated to automation for this screen-
ing site was large and ideally located in the middle of the
department; no options were available, but none was
needed.
Possibilities for laboratory design were virtually unlim-
ited and the decisions regarding the design of the lab that
was built were numerous. The outcome is described
below.
Space--decisions
Fortuitously, we were given a very large, unfinished
space in which to build the central robotics laboratory.
The space is located in the middle of the department,
allowing easy access to all scientists. With the help of a
large number and wide variety of facilities engineers,
laboratory construction experts, cell-based assay experts,
automation experts and assorted laboratory planners, a
detailed set of plans was drawn up and construction was
completed in less than 10 months.
The robotics laboratory was designed to ensure easy
installation and continuous operation of robot systems
and to allow the flexibility to adapt to future changes in
technology and/or workflow. Utilities that were installed
to support the systems included air, vacuum, nitrogen,
helium, carbon dioxide and clean water, auxiliary lines
were installed for future needs. The systems had network
and telephone connections, and power back-up by both
generator and uninterruptible power supply. Cell culture
rooms, autoclave, cold storage, and consumables storage
were built with easy access to the robots and their users in
mind. Most reagents are stored in the assay developers’
laboratories, but accommodations were made to ensure
convenience to the robot systems. Most benches in the
laboratory have wheels; only those with sinks and utility
connections are fixed.
The laboratory environmental conditions were also im-
portant. The laboratory temperature is held in a narrow
range that is slightly colder than ambient for the build-
ing; the temperature is maintained in that range for
24hours. Freezers are also maintained in a narrow
temperature range and are alarmed. Attention was
paid to the aesthetics of the laboratory; colour selections
for cabinets and walls were taken very seriously. We
believe that because the people working there spend
more of their time there than almost anywhere else that
they should spend that time in a pleasant environment.
During the 10 months that the permanent laboratory was
designed and built, a laboratory adjacent to it was
modified to allow immediate installation of robot systems
and automation of high throughput screens. Laboratory
benches and cabinets were removed and utilities were
installed to support full robot track systems; the labora-
tory was converted to support robots quickly. Addition-
ally, laboratories throughout the department were
modified to accommodate installation of standalone
automated workstations.
Results
Development and implementation of these site-specific
plans started in May 1996 and were completed in March
1997; all except the construction of the new laboratory
were completed before the end of 1996. All high through-
put screening, all compound preparation and most
secondary screening activities in the department were
automated in that timeframe.
Projects continue to expand, people continue to be
trained, processes continue to be improved and tech-
nology will continue to evolve. Goals for the near future
are focused on continuous improvement of the processes
developed in the first year. Quality, not quantity, is the
current focus and cost containment is always important.
Many projects are in place that will ensure the long-term
success of screening at this site and ofGW drug discovery.
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